The key findings we provide are briefly i) subjects with FL and NASH exhibit quite the same elevated values of serum TGF-β1, both greater than those present in CHC patients; ii) there is a fair correlation between levels of this cytokine and ferritin in FL patients. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.